Neil P. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Neil P. Patel has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Khawar Hussain
Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust , London
18 shared publications Nada Khalil
Imperial College Healthcare NHS Trust , London
11 shared publications- Laksha Bala
Department of Dermatology, Charing Cross Hospital, Imperial College Healthcare NHS Trust , London
5 shared publications James Carton
Imperial College Healthcare NHS Trust , London
3 shared publicationsKhawar Hussain
Department of Dermatology, Imperial College Healthcare NHS Trust , London , UK
3 shared publicationsVani Agarwal
Imperial College Healthcare NHS Trust , London
3 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Managing chaperone refusal in intimate dermatological examinations
We present an ethical dilemma involving a competent adult requiring an intimate dermatological examination who requests to proceed without a chaperone. We explore the key ethical considerations, including autonomy, dignity and professional accountability, and outline an appropriate, patient-centred approach to management.
- 3 August 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Open AccessManaging chaperone refusal in intimate dermatological examinations
We present an ethical dilemma involving a competent adult requiring an intimate dermatological examination who requests to proceed without a chaperone. We explore the key ethical considerations, including autonomy, dignity and professional accountability, and outline an appropriate, patient-centred approach to management.
- Open Access
- 1 August 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Patient-requested surveillance for suspected acral melanoma: balancing autonomy and clinical risk
A patient with suspected acral melanoma requested surveillance rather than the recommended urgent excision biopsy. This raises a conflict between respect for patient autonomy and the need for timely investigation of a potentially serious malignancy. We explore how clinicians should respond when a capacitous patient declines the recommended cancer pathway.
- 1 August 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Open AccessPatient-requested surveillance for suspected acral melanoma: balancing autonomy and clinical risk
A patient with suspected acral melanoma requested surveillance rather than the recommended urgent excision biopsy. This raises a conflict between respect for patient autonomy and the need for timely investigation of a potentially serious malignancy. We explore how clinicians should respond when a capacitous patient declines the recommended cancer pathway.
- Open Access
- 17 July 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (11) , 2176-2177
Missed melanoma following skin lesion triage by an autonomous artificial intelligence system in a community setting
Skin lesion triage by artificial intelligence (AI) has the potential to improve access to dermatology services but raises important ethical and governance challenges. This fictional case examines a missed melanoma following autonomous AI assessment during a pilot programme in the community, prompting a safety review. It highlights concerns regarding patient safety, informed consent, accountability for diagnostic error and the need for robust oversight when integrating AI into clinical pathways.
- 17 July 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (11) , 2176-2177
Open AccessMissed melanoma following skin lesion triage by an autonomous artificial intelligence system in a community setting
Skin lesion triage by artificial intelligence (AI) has the potential to improve access to dermatology services but raises important ethical and governance challenges. This fictional case examines a missed melanoma following autonomous AI assessment during a pilot programme in the community, prompting a safety review. It highlights concerns regarding patient safety, informed consent, accountability for diagnostic error and the need for robust oversight when integrating AI into clinical pathways.
- 2 May 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (9) , 1748-1750
Reactive infectious mucocutaneous eruption triggered by rhinovirus and β-haemolytic streptococcus co-infection
We describe a reactive infectious mucocutaneous eruption (RIME) triggered by co-infection with rhinovirus and β-haemolytic streptococcus. This presentation suggests that distinct pathogens may act synergistically to produce a powerful host immunological response, resulting in striking mucocutaneous clinical features. Our case illustrates the importance of screening for a broad range of respiratory pathogens, as positive findings may aid in the diagnosis of RIME and inform the choice of targeted antimicrobial therapy.
- 2 May 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (9) , 1748-1750
Reactive infectious mucocutaneous eruption triggered by rhinovirus and β-haemolytic streptococcus co-infection
We describe a reactive infectious mucocutaneous eruption (RIME) triggered by co-infection with rhinovirus and β-haemolytic streptococcus. This presentation suggests that distinct pathogens may act synergistically to produce a powerful host immunological response, resulting in striking mucocutaneous clinical features. Our case illustrates the importance of screening for a broad range of respiratory pathogens, as positive findings may aid in the diagnosis of RIME and inform the choice of targeted antimicrobial therapy.
- 17 February 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (7) , 1306-1307
Glucagon-like peptide-1 (GLP-1) and dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonists in dermatology: only one piece of the puzzle
GLP-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/GLP-1 RAs show promise for managing obesity-associated inflammatory skin diseases, including psoriasis and hidradenitis suppurativa. However, treatment discontinuation often leads to rapid weight regain and reversal of metabolic improvements, raising concerns about potential relapse of skin disease. Behavioural modification remains essential for maintaining therapeutic gains. Clinicians should prioritize structured lifestyle support, patient education and continuing monitoring alongside pharmacotherapy.
- 17 February 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (7) , 1306-1307
Glucagon-like peptide-1 (GLP-1) and dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonists in dermatology: only one piece of the puzzle
GLP-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/GLP-1 RAs show promise for managing obesity-associated inflammatory skin diseases, including psoriasis and hidradenitis suppurativa. However, treatment discontinuation often leads to rapid weight regain and reversal of metabolic improvements, raising concerns about potential relapse of skin disease. Behavioural modification remains essential for maintaining therapeutic gains. Clinicians should prioritize structured lifestyle support, patient education and continuing monitoring alongside pharmacotherapy.
- 4 December 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (3) , 514-515
Janus kinase inhibitors in severe alopecia areata: balancing patient expectations with clinician safety considerations
An ethical dilemma of a patient with severe alopecia areata insisting on treatment with a novel oral Janus kinase inhibitor, despite the dermatologist expressing reservations about the patient’s cardiovascular risk factors.
- 4 December 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (3) , 514-515
Janus kinase inhibitors in severe alopecia areata: balancing patient expectations with clinician safety considerations
An ethical dilemma of a patient with severe alopecia areata insisting on treatment with a novel oral Janus kinase inhibitor, despite the dermatologist expressing reservations about the patient’s cardiovascular risk factors.
- 27 September 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (1) , 177-178
Formulation and systemic therapy
A Specialty Certificate Examination case testing knowledge of systemic therapies for severe alopecia areata.
- 27 September 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (1) , 177-178
Formulation and systemic therapy
A Specialty Certificate Examination case testing knowledge of systemic therapies for severe alopecia areata.
- 25 July 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (11) , 2310-2311
Risk factors associated with nonattendance at new general dermatology appointments: a single-centre study
Reducing nonattendance at dermatology appointments is important to improve efficiency, reduce waiting lists and improve patient outcomes. We conducted a retrospective observational study to identify risk factors for nonattendance at new general dermatology appointments at our centre. We identified that waiting times were significantly higher for nonattendees compared with attendees (median 284 vs. 158 days, P = 0.005). This suggests that, for our service at least, interventions to reduce waiting times may improve attendance rates.
- 25 July 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (11) , 2310-2311
Risk factors associated with nonattendance at new general dermatology appointments: a single-centre study
Reducing nonattendance at dermatology appointments is important to improve efficiency, reduce waiting lists and improve patient outcomes. We conducted a retrospective observational study to identify risk factors for nonattendance at new general dermatology appointments at our centre. We identified that waiting times were significantly higher for nonattendees compared with attendees (median 284 vs. 158 days, P = 0.005). This suggests that, for our service at least, interventions to reduce waiting times may improve attendance rates.
- 25 April 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (8) , 1669-1671
Severely dysplastic naevi: a call for national guidance
There are currently no guidelines for the management of severely dysplastic naevi (SDN), either in the UK or internationally. There is a consensus for re-excision of SDN with positive margins. However, there is variation in clinical practice in the management of completely excised SDN. We carried out a retrospective observational study reviewing the management of SDN across two NHS trusts in the UK over a 5-year period. Our results demonstrate considerable variation in practice between the two trusts and potential overtreatment of completely excised SDN. This highlights the need for consensus-based and evidence-based guidelines to standardize care for patients with SDN.
- 25 April 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (8) , 1669-1671
Severely dysplastic naevi: a call for national guidance
There are currently no guidelines for the management of severely dysplastic naevi (SDN), either in the UK or internationally. There is a consensus for re-excision of SDN with positive margins. However, there is variation in clinical practice in the management of completely excised SDN. We carried out a retrospective observational study reviewing the management of SDN across two NHS trusts in the UK over a 5-year period. Our results demonstrate considerable variation in practice between the two trusts and potential overtreatment of completely excised SDN. This highlights the need for consensus-based and evidence-based guidelines to standardize care for patients with SDN.
- 24 October 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (4) , 854-856
A survey of smoking habits and perspectives in patients with hidradenitis suppurativa
Patients attending the hidradenitis suppurativa (HS) clinic at our centre were surveyed about their smoking habits and their perspectives on the relationship between smoking and HS. In total, 27 of 34 patients (73.0%) had a smoking history, and age of onset of smoking preceded age of onset of HS in 81.5%, with an average time interval of 5 years. There were mixed patient perceptions on the role of smoking in HS, highlighting the need for more research in this area, and the importance of engaging and educating patients on the results of epidemiological studies in HS.
- 24 October 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (4) , 854-856
A survey of smoking habits and perspectives in patients with hidradenitis suppurativa
Patients attending the hidradenitis suppurativa (HS) clinic at our centre were surveyed about their smoking habits and their perspectives on the relationship between smoking and HS. In total, 27 of 34 patients (73.0%) had a smoking history, and age of onset of smoking preceded age of onset of HS in 81.5%, with an average time interval of 5 years. There were mixed patient perceptions on the role of smoking in HS, highlighting the need for more research in this area, and the importance of engaging and educating patients on the results of epidemiological studies in HS.